-       Report 
- October 2025
- Europe 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- Global 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- Global 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- China 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- United States 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
             -       Report 
- October 2025
- United Kingdom 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- North America 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- Europe 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- Middle East 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- Asia Pacific 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- China 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- North America 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
            -       Report 
- October 2025
- Europe 
   From       €1864EUR$2,095USD£1,641GBP 
      €3551EUR$3,990USD£3,125GBP 
          -       Report 
- January 2025
-  132 Pages 
- Global 
   From       €845EUR$950USD£744GBP 
          -       Report 
- October 2025
-  50 Pages 
- Global 
   From       €2358EUR$2,650USD£2,076GBP 
          -       Report 
- October 2025
-  50 Pages 
- Global 
   From       €2358EUR$2,650USD£2,076GBP 
          -       Report 
- October 2025
-  50 Pages 
- Global 
   From       €2358EUR$2,650USD£2,076GBP 
          -       Report 
- October 2025
-  50 Pages 
- Global 
   From       €2358EUR$2,650USD£2,076GBP 
          -       Report 
- October 2025
-  50 Pages 
- Global 
   From       €2358EUR$2,650USD£2,076GBP 
          -       Report 
- October 2025
-  30 Pages 
- Europe 
   From       €1691EUR$1,900USD£1,488GBP 
       
      Ammonium Chloride is a common ingredient in cough and cold drugs. It is used to reduce the thickness of mucus, making it easier to expel from the body. It is also used to reduce the irritation of the throat and to reduce the severity of coughing. Ammonium Chloride is available in many forms, including tablets, capsules, syrups, and lozenges. It is also available in combination with other ingredients, such as antihistamines, decongestants, and expectorants.
Ammonium Chloride is widely used in cough    and cold drugs, and is available in many countries around the world. It is generally considered safe and effective when used as directed. However, it can cause side effects such as nausea, vomiting, and diarrhea.
Some of the companies that produce cough and cold drugs containing Ammonium Chloride include GlaxoSmithKline, Pfizer, Merck, and Johnson & Johnson. Show Less   Read more